HealthCor Management, L.P. - Q4 2022 holdings

$109 Million is the total value of HealthCor Management, L.P.'s 22 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 84.5% .

 Value Shares↓ Weighting
BMRN SellBIOMARIN PHARMACEUTICAL INC$38,059,999
-40.8%
367,765
-51.5%
34.88%
+333.5%
DXCM BuyDEXCOM INC$36,393,071
+78.2%
321,380
+26.8%
33.35%
+1206.5%
CYTK SellCYTOKINETICS INC$7,534,640
-64.2%
164,440
-62.2%
6.90%
+162.2%
NewACRIVON THERAPEUTICS INC$3,273,995284,201
+100.0%
3.00%
BuyHYPERFINE INC$3,259,956
+46.4%
3,880,900
+41.2%
2.99%
+971.0%
ALKS SellALKERMES PLC$2,874,300
-57.6%
110,000
-63.8%
2.63%
+210.6%
CNMD NewCONMED CORP$2,437,60027,500
+100.0%
2.23%
NBIX SellNEUROCRINE BIOSCIENCES INC$2,388,800
+3.5%
20,000
-7.9%
2.19%
+657.4%
SNDX SellSYNDAX PHARMACEUTICALS INC$1,781,500
-91.4%
70,000
-91.9%
1.63%
-36.8%
KDNY SellCHINOOK THERAPEUTICS INC$1,572,000
-70.0%
60,000
-77.5%
1.44%
+119.7%
ISRG NewINTUITIVE SURGICAL INC$1,525,7625,750
+100.0%
1.40%
BPMC SellBLUEPRINT MEDICINES CORP$1,314,300
-80.9%
30,000
-71.3%
1.20%
+39.8%
GERN SellGERON CORP$1,210,000
-72.8%
500,000
-73.7%
1.11%
+99.1%
PEN NewPENUMBRA INC$1,112,3005,000
+100.0%
1.02%
RCKT SellROCKET PHARMACEUTICALS INC$978,500
-86.2%
50,000
-88.8%
0.90%
+1.0%
RAIN NewRAIN ONCOLOGY INC$960,000120,000
+100.0%
0.88%
INSP SellINSPIRE MED SYS INC$881,580
-87.0%
3,500
-90.8%
0.81%
-4.7%
SILK NewSILK RD MED INC$792,75015,000
+100.0%
0.73%
IMGN SellIMMUNOGEN INC$744,000
-88.0%
150,000
-88.5%
0.68%
-12.2%
 EQRX INC*w exp 12/17/202$9,451
-67.4%
35,2390.0%0.01%
+125.0%
EUCRW  EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202$4,340
+117.0%
78,0590.0%0.00%
MSACW  MEDICUS SCIENCES ACQUISITION*w exp 02/12/202$2,679
+167.9%
29,7760.0%0.00%
OHPAW ExitORION ACQUISITION CORP*w exp 02/19/202$0-50,105
-100.0%
0.00%
LGVWS ExitLONGVIEW ACQUISITION CORP II*w exp 99/99/999$0-149,999
-100.0%
-0.00%
IKNA ExitIKENA ONCOLOGY INC$0-220,082
-100.0%
-0.10%
LPTX ExitLEAP THERAPEUTICS INC$0-1,066,689
-100.0%
-0.12%
ISEE ExitIVERIC BIO INC$0-85,230
-100.0%
-0.19%
RVNC ExitREVANCE THERAPEUTICS INC$0-64,590
-100.0%
-0.22%
NTRA ExitNATERA INC$0-65,130
-100.0%
-0.36%
BLUE ExitBLUEBIRD BIO INC$0-455,000
-100.0%
-0.36%
NVRO ExitNEVRO CORP$0-67,600
-100.0%
-0.39%
NEO ExitNEOGENOMICS INC$0-391,110
-100.0%
-0.42%
CANO ExitCANO HEALTH INC$0-395,560
-100.0%
-0.43%
AFMD ExitAFFIMED N V$0-1,721,925
-100.0%
-0.44%
XRAY ExitDENTSPLY SIRONA INC$0-158,200
-100.0%
-0.56%
MRUS ExitMERUS N V$0-272,890
-100.0%
-0.68%
SWAV ExitSHOCKWAVE MED INC$0-19,720
-100.0%
-0.69%
SGEN ExitSEAGEN INC$0-57,340
-100.0%
-0.98%
HOLX ExitHOLOGIC INC$0-137,330
-100.0%
-1.11%
MOH ExitMOLINA HEALTHCARE INC$0-27,540
-100.0%
-1.14%
ABT ExitABBOTT LABS$0-98,970
-100.0%
-1.20%
MCK ExitMCKESSON CORP$0-35,040
-100.0%
-1.49%
CVS ExitCVS HEALTH CORP$0-131,150
-100.0%
-1.56%
KZR ExitKEZAR LIFE SCIENCES INC$0-1,607,650
-100.0%
-1.73%
BDX ExitBECTON DICKINSON & CO$0-62,930
-100.0%
-1.75%
HZNP ExitHORIZON THERAPEUTICS PUB L$0-229,530
-100.0%
-1.78%
INCY ExitINCYTE CORP$0-227,851
-100.0%
-1.90%
BMY ExitBRISTOL-MYERS SQUIBB CO$0-223,150
-100.0%
-1.98%
HSIC ExitHENRY SCHEIN INC$0-248,920
-100.0%
-2.05%
LIVN ExitLIVANOVA PLC$0-328,030
-100.0%
-2.08%
AMGN ExitAMGEN INC$0-75,370
-100.0%
-2.12%
ANTM ExitELEVANCE HEALTH INC$0-38,910
-100.0%
-2.21%
BIIB ExitBIOGEN INC$0-69,950
-100.0%
-2.34%
HUM ExitHUMANA INC$0-42,920
-100.0%
-2.60%
CI ExitCIGNA CORP NEW$0-76,910
-100.0%
-2.67%
CNC ExitCENTENE CORP DEL$0-300,970
-100.0%
-2.93%
TMO ExitTHERMO FISHER SCIENTIFIC INC$0-51,240
-100.0%
-3.25%
THC ExitTENET HEALTHCARE CORP$0-518,990
-100.0%
-3.35%
DHR ExitDANAHER CORPORATION$0-117,800
-100.0%
-3.80%
UNH ExitUNITEDHEALTH GROUP INC$0-62,980
-100.0%
-3.98%
ABC ExitAMERISOURCEBERGEN CORP$0-239,150
-100.0%
-4.05%
LLY ExitLILLY ELI & CO$0-103,150
-100.0%
-4.17%
BSX ExitBOSTON SCIENTIFIC CORP$0-958,600
-100.0%
-4.64%
A ExitAGILENT TECHNOLOGIES INC$0-338,030
-100.0%
-5.14%
ABBV ExitABBVIE INC$0-310,250
-100.0%
-5.21%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HCA HOLDINGS INC27Q1 20226.2%
ZIMMER HLDGS INC26Q2 20229.3%
DANAHER CORPORATION26Q3 20225.6%
NEUROCRINE BIOSCIENCES INC26Q4 20227.8%
UNITEDHEALTH GROUP INC24Q3 20226.4%
VERTEX PHARMACEUTICALS INC24Q3 20215.3%
HUMANA INC22Q3 20226.6%
BRISTOL-MYERS SQUIBB CO22Q3 20229.2%
BIOGEN INC21Q3 20228.5%
LABORATORY CORP AMER HLDGS20Q2 20208.3%

View HealthCor Management, L.P.'s complete holdings history.

Latest significant ownerships (13-D/G)
HealthCor Management, L.P. Q4 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
CareView Communications IncMay 26, 2023186,970,00032.0%
Research Alliance Corp. IISold outFebruary 14, 202300.0%
ARYA Sciences Acquisition Corp IVSold outFebruary 14, 202200.0%
Aurinia Pharmaceuticals Inc.Sold outFebruary 14, 202200.0%
MADRIGAL PHARMACEUTICALS, INC.Sold outFebruary 14, 202200.0%
Medicus Sciences Acquisition Corp.Sold outFebruary 14, 202200.0%
Arcturus Therapeutics Holdings Inc.Sold outFebruary 12, 202100.0%
Intersect ENT, Inc.Sold outFebruary 12, 202100.0%
NEVRO CORPFebruary 12, 2021156,0460.5%
ViewRay, Inc.Sold outFebruary 12, 202100.0%

View HealthCor Management, L.P.'s complete significant-ownership history.

Latest filings
TypeFiled
42023-05-26
42023-05-26
SC 13D/A2023-05-26
42023-04-04
42023-04-04
SC 13D/A2023-04-03
13F-HR2023-02-15
SC 13G/A2023-02-14
42023-01-04
42023-01-04

View HealthCor Management, L.P.'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (109111527.0 != 109111523.0)

Export HealthCor Management, L.P.'s holdings